New hope for hard-to-treat breast cancer: drug combo trial launches
Disease control
ENROLLING_BY_INVITATION
This study tests a new drug called HB0025 combined with chemotherapy (Nab-Paclitaxel) as a first treatment for people with advanced triple-negative breast cancer that cannot be removed by surgery. The goal is to see if the combination is safe and works better than chemo alone. Ab…
Phase: PHASE2 • Sponsor: Huabo Biopharm Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC